Skip to main content
main-content
Top

22-06-2017 | Nivolumab | Article

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

Carbone DP et al. N Engl J Med 2017; 376: 2415-2426. doi: 10.1056/NEJMoa1613493

Please log in to get access to this content

Related topics